Overview


According to FutureWise analysis the market for clinical laboratory tests in 2023 is US$ 113.64 million, and is expected to reach US$ 236.95  million by 2031 at a CAGR of 9.60%.

Clinical laboratory tests are an essential component of modern medicine, providing diagnostic and monitoring services to healthcare providers and patients. These tests involve the analysis of bodily fluids, tissues, and other substances to detect, diagnose, and manage medical conditions. Clinical laboratory tests are performed in a controlled environment, such as a hospital or independent laboratory, using specialized equipment and techniques. They encompass a wide range of tests, including blood tests, urine tests, genetic tests, and infectious disease tests.

Blood tests are one of the most commonly performed clinical laboratory tests and are used to diagnose a range of medical conditions, such as anemia, infections, and metabolic disorders. Urine tests are another commonly performed test and are used to detect the presence of substances such as glucose, protein, and blood in the urine, which can indicate underlying medical conditions. Genetic tests are used to identify changes in an individual's DNA that may be associated with an increased risk of developing certain medical conditions. These tests are becoming increasingly popular as part of personalized medicine, allowing for early identification and prevention of genetic disorders. Infectious disease tests are used to detect the presence of infectious agents, such as viruses, bacteria, and fungi, in the body. These tests are critical in identifying and managing outbreaks of infectious diseases, such as COVID-19, and in monitoring the effectiveness of treatments.

FutureWise Market Research has published a report that provides an insightful analysis of Clinical Laboratory Test Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Clinical Laboratory Test Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Abbott Laboratories, Inc.
  • Quest Diagnostics, Inc.
  • Sonic Healthcare Ltd.
  • Siemens Healthineers
  • Laboratory Corporation of America, LLC.
  • OPKO Health, Inc.
  • Charles River Laboratories International, Inc.
  • Genoptix, Inc.
  • NeoGenomics Laboratories Inc.
  • Eurofins Scientific
  • Fresenius Medical Care
  • Bioscientia Institut für Medizinische Diagnostik GmbH

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Clinical Laboratory Test Market:

In September 2022, Optical genome mapping (OGM) data services from Bionano and the clinical testing services formerly provided by Lineagen were combined into a new company called Bionano Labs, according to a press release from Bionano Genomics Inc. It also revealed the launch of the first OGM-based test created by Bionano Labs.

The clinical laboratory test market refers to the industry that provides diagnostic testing services to healthcare providers and patients. Clinical laboratory tests are essential for diagnosing and monitoring various medical conditions, such as infectious diseases, cancer, and metabolic disorders. The clinical laboratory test market is driven by several factors, including the growing prevalence of chronic diseases, increasing demand for personalized medicine, and advancements in technology and automation. Additionally, the COVID-19 pandemic has significantly impacted the clinical laboratory test market, with increased demand for diagnostic testing services to identify and monitor the spread of the virus. The clinical laboratory test market is highly competitive and fragmented, with many small and large players operating in the market. The industry is characterized by rapid technological advancements, with companies constantly developing new testing platforms and assays to improve accuracy, speed, and ease of use.

Furthermore, the clinical laboratory test market is highly regulated, with strict guidelines and quality control standards to ensure accurate and reliable results. Regulatory bodies, such as the U.S. FDA, play a critical role in overseeing the development and approval of new diagnostic tests and ensuring that they meet safety and efficacy standards.

By Test Type

  • Complete Blood Count (CBC)
  • HGB/HCT
  • Electrolytes Testing
  • BUN Creatinine Tests
  • Comprehensive Metabolic Panel
  • Basic Metabolic Panel
  • HbA1c Tests
  • Liver Panel
    •  Bile Duct Obstruction
    •  Autoimmune Disorders
    •  Hepatitis
    •  Liver Cancer
    •  Liver Cirrhosis
    •  Bone disease
    •  Others
  • Lipid Panel
  • Renal Panel
  • Prothrombin Time
  • Thyroid Stimulating Hormone
  • Cultures
  • Others 

By Specialty

  • Clinical Chemistry Testing
    •  Routine Chemistry Testing
    •  Specialized Chemistry Testing
    •  Endocrinology Chemistry Testing
    •  Therapeutic Drug Monitoring (TDM) Testing
    •  Others
  • Microbiology Testing
    •  Infectious Disease Testing
    •  Transplant Diagnostic Testing
    •  Others
  • Genetic Testing
  • Cytology Testing
  • Immunology Testing
  • Hematology Testing
  • Drug of Abuse Testing

By Department

  • Genetics
  • Hematology
  • Virology
  • Parasitology
  • Toxicology
  • Histopathology
  • Microbiology
  • Clinical Biochemistry
  • Urinalysis
  • Cytopathology
  • Immunology/Serology
  • Surgical Pathology
  • Others

By Service Provider

  • Hospital-based Laboratories
  • Clinic-based Laboratories
  • Stand-alone Laboratories

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. The presence of major firms and governmental agencies in the region is the primary factor fueling the market's expansion for clinical laboratory tests in North America since it raises public awareness and makes it easier for people to acquire services. For instance, the American Clinical Laboratories Association is a non-profit group that provides its members with education, information, and research opportunities. Other significant factors propelling the growth of the market under study in the North American region include the high burden of chronic diseases in the region and the rising demand for early diagnostics. Along with new launches, acquisitions, partnerships, and the presence of major market players in the nation are all anticipated to support the expansion of the clinical laboratory test market. As a result of the aforementioned reasons, it is anticipated that over the projected period, the North American region will hold a significant market share in the market under consideration.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Clinical Laboratory Tests Market By Test Type, By Specialty, By Department, By Service Provider and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Clinical Laboratory Tests Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Clinical Laboratory Tests Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Clinical Laboratory Tests Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Clinical Laboratory Tests Market, By Test Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Complete Blood Count (CBC)
        2. HGB/HCT
        3. Electrolytes Testing
        4. BUN Creatinine Tests
        5. Comprehensive Metabolic Panel
        6. Basic Metabolic Panel
        7. HbA1c Tests
        8. Liver Panel
         8.1. Bile Duct Obstruction
         8.2. Autoimmune Disorders
         8.3. Hepatitis
         8.4. Liver Cancer
         8.5. Liver Cirrhosis
         8.6. Bone disease
         8.7. Others
        9. Lipid Panel
        10. Renal Panel
        11. Prothrombin Time
        12. Thyroid Stimulating Hormone
        13. Cultures
        14. Others

  • 8.   Clinical Laboratory Tests Market, By Specialty Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Clinical Chemistry Testing
         1.1. Routine Chemistry Testing
         1.2. Specialized Chemistry Testing
         1.3. Endocrinology Chemistry Testing
         1.4. Therapeutic Drug Monitoring (TDM) Testing
         1.5. Others
        2. Microbiology Testing
         2.1. Infectious Disease Testing
         2.2. Transplant Diagnostic Testing
         2.3. Others
        3. Genetic Testing
        4. Cytology Testing
        5. Immunology Testing
        6. Hematology Testing
        7. Drug of Abuse Testing

  • 9.   Clinical Laboratory Tests Market, By Department Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Genetics
        2. Hematology
        3. Virology
        4. Parasitology
        5. Toxicology
        6. Histopathology
        7. Microbiology
        8. Clinical Biochemistry
        9. Urinalysis
        10. Cytopathology
        11. Immunology/Serology
        12. Surgical Pathology
        13. Others

  • 10.   Clinical Laboratory Tests Market, By Service Provider Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospital-based Laboratories
        2. Clinic-based Laboratories
        3. Stand-alone Laboratories

  • 11.   North America Clinical Laboratory Tests Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Clinical Laboratory Tests Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Clinical Laboratory Tests Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Clinical Laboratory Tests Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Abbott Laboratories, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Quest Diagnostics, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Sonic Healthcare Ltd.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Siemens Healthineers
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Laboratory Corporation of America, LLC.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. OPKO Health, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Charles River Laboratories International, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Genoptix, Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. NeoGenomics Laboratories Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Eurofins Scientific
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Fresenius Medical Care
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Bioscientia Institut für Medizinische Diagnostik GmbH
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11